What is a 10-Q/A filing?

Any registrant that has previously filed a Form 10-Q can file a 10-Q/A to amend that prior filing. There is no statutory deadline — amendments may be filed at any time. In practice, 10-Q/A filings cluster in three windows: (a) days-to-weeks after the original 10-Q if a material error is caught immediately; (b) months later as part of an annual-audit reconciliation that surfaces quarterly mis-statements; (c) years later as part of a full restatement (often coordinated across multiple quarters and the related 10-K).

Note that 10-Q/A is distinct from a Non-Reliance 8-K (Item 4.02) — the 8-K announces that prior financials cannot be relied on; the 10-Q/A is the substantive restatement document. The two filings often appear within days of each other; the 8-K precedes the 10-Q/A as the formal investor-facing notice.

The Explanatory Note at the front of a 10-Q/A is the most important section. It states:

• What the amendment changes — specific line items being restated, specific Items being amended (Part I Item 1 Financial Statements, Part I Item 2 MD&A, Part II Item 4 Controls, etc.).
• Why the amendment was necessary — restatement of revenue recognition, correction of cut-off error, deferred-tax mis-application, classification change, etc.
• Whether prior financials should not be relied on — explicit cross-reference to any Item 4.02 8-K filed in connection with the amendment.
• Internal-control conclusions — whether the restatement reflects a material weakness in internal control over financial reporting (ICFR). If yes, the Item 4 conclusion in the original 10-Q is necessarily revised.

The body of the 10-Q/A then carries the restated financial statements + revised MD&A discussion + whatever other Items required amendment. Unchanged Items are typically incorporated by reference rather than re-disclosed.

A 10-Q/A is almost never benign for the share price. The Explanatory Note tells you exactly what management is conceding was wrong; the restated financials show the magnitude. Restatement events typically see negative abnormal returns in the 5-10 day window post-filing, with magnitude correlated to: (a) percentage change in reported income, (b) whether a material weakness in ICFR is disclosed, (c) auditor turnover within 12 months, and (d) whether the SEC has commenced a formal inquiry.

The Sarbanes-Oxley Section 906 certification on the 10-Q/A is signed afresh by the CEO and CFO; the certification language is the same as on a clean 10-Q, but signing it on a restatement document carries personal legal exposure that operating executives are aware of.